Showing 15,481 - 15,500 results of 122,478 for search '(( 2 d decrease ) OR ( 5 ((point decrease) OR (((nn decrease) OR (a decrease)))) ))', query time: 1.91s Refine Results
  1. 15481

    Conditional latent growth curve models (CLGCMs). by Chiara Remondi (15301459)

    Published 2023
    “…Results of univariate latent growth models showed a cubic trend of mothers’ PSE, which revealed a decreasing pattern characterized initially by a slight decline, followed by a rebound before continuously decreasing. …”
  2. 15482

    Unconditional latent curve model for mothers. by Chiara Remondi (15301459)

    Published 2023
    “…Results of univariate latent growth models showed a cubic trend of mothers’ PSE, which revealed a decreasing pattern characterized initially by a slight decline, followed by a rebound before continuously decreasing. …”
  3. 15483

    S1 Data - by Chiara Remondi (15301459)

    Published 2023
    “…Results of univariate latent growth models showed a cubic trend of mothers’ PSE, which revealed a decreasing pattern characterized initially by a slight decline, followed by a rebound before continuously decreasing. …”
  4. 15484
  5. 15485

    Bone mechanical properties assessed by three-point bending tests in rat femur. by Bruno Vidal (685974)

    Published 2018
    “…<p>Results showed that arthritic rats at day 22 have decreased properties at yield point, related to displacement (A), strength (B) and energy (elastic energy) (C). …”
  6. 15486

    Expression of the ETS-5 target gene <i>gcy-9</i> restores CO<sub>2</sub>-chemosensitivity to <i>ets-5</i> mutants. by Julia P. Brandt (176082)

    Published 2012
    “…Wild-type URX neurons (top panel) showed a small decrease in the ratio of YFP:CFP emissions in response to 10 s CO<sub>2</sub> pulses indicating decreases in cell calcium. …”
  7. 15487
  8. 15488
  9. 15489

    Efficacy of Rituximab in Refractory Inflammatory Myopathies Associated with Anti- Synthetase Auto-Antibodies: An Open-Label, Phase II Trial by Yves Allenbach (483114)

    Published 2015
    “…Corticosteroid doses decreased from 52.5 mg/d (range, 10–70) to 9 mg/d (range, 7–65) and six patients had a decrease in the burden of their associated immunosuppressants. …”
  10. 15490
  11. 15491
  12. 15492
  13. 15493

    Antinociceptive effect of N-(9,13b-dihydro-1H-dibenzo[c,f]imidazo[1,5-a]azepin-3-yl)-2-hydroxybenzamide on different pain models in mice by Hee-Jung Lee (297255)

    Published 2022
    “…<div><p>Abstract N-(9,13b-dihydro-1H-dibenzo[c,f]imidazo[1,5-a]azepin-3-yl)-2-hydroxybenzamide (DDIAHB) is a new drug developed through molecular modelling and rational drug design by the molecular association of epinastine and salicylic acid. …”
  14. 15494
  15. 15495

    A synthetic lethal screen identifies the Vitamin D receptor as a novel gemcitabine sensitizer in pancreatic cancer cells by V Bhattacharjee (681247)

    Published 2015
    “…VDR knockdown disrupted the cells’ ability to form phospho-γH2AX and Rad51 foci in response to gemcitabine treatment. …”
  16. 15496
  17. 15497
  18. 15498
  19. 15499
  20. 15500